BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

3 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer.BDB
Chinese Academy of Sciences
Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR.BDB
Chemical Genomics Centre of The Max Planck Society
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.BDB
Harvard Medical School